QHSLab secures $297K grant from global consumer health firm for allergic rhinitis digital study

QHSLab, Inc.

QHSLab received $297,360 grant from a Global Leader in Consumer Health to advance digital medicine for allergic rhinitis.
Study registered as NCT06603935 on ClinicalTrials.gov; titled 'Harnessing Digital Medicine Tools...'
Research will evaluate QHSLab's AME and ARIS digital tools for primary care allergy management.
Principal Investigator: Marcos Sanchez-Gonzalez, MD, PhD; study aims to improve patient outcomes and reduce costs.
Grant reflects shared commitment to digital health innovation and evidence-based self-care for patients.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.